Meta-analysis of transanal versus laparoscopic total mesorectal excision for rectal cancer: a ‘New Health Technology’ assessment in South Korea

다국어 초록 (Multilingual Abstract)

Purpose: Under the South Korea’s unique health insurance structure, any new surgical technology must be evaluated first by the government in order to consider whether that particular technology can be applied to patients for further clinical trials as categorized as ‘New Health Technology,’ then potentially covered by the insurance sometime later. The aim of this meta-analysis was to assess the safety and efficacy of transanal total mesorectal excision (TaTME) for rectal cancer, activated by the National Evidence-based Healthcare Collaborating Agency (NECA) TaTME committee.
Methods: We systematically searched Ovid-MEDLINE, Ovid-Embase, Cochrane, and Korean databases (from their inception until August 31, 2019) for studies published that compare TaTME with laparoscopic total mesorectal excision (LaTME). End-points included perioperative and pathological outcomes.
Results: Sixteen cohort studies (7 for case-matched studies) were identified, comprising 1,923 patients (938 TaTMEs and 985 LaTMEs). Regarding perioperative outcomes, the conversion rate was significantly lower in TaTME (risk ratio, 0.19; 95% confidence interval, 0.11–0.34; P < 0.001); whereas other perioperative outcomes were similar to LaTME. There were no statistically significant differences in pathological results between the 2 procedures.
Conclusion: Our meta-analysis showed comparable results in preoperative and pathologic outcomes between TaTME and LaTME, and indicated the benefit of TaTME with low conversion. Extensive evaluations of well-designed, multicenter randomized controlled trials are required to come to unequivocal conclusions, but the results showed that TaTME is a potentially beneficial technique in some specific cases. This meta-analysis suggests that TaTME can be performed for rectal cancer patients as a ‘New Health Technology’ endorsed by NECA in South Korea.

목차 (Table of Contents)

• INTRODUCTION
• METHODS
• RESULTS
• DISCUSSION
• REFERENCES

참고문헌 (Reference)

1 Sylla P, "Urethral injury and other urologic injuries during transanal total mesorectal excision: an international collaborative study" 274 : e115-e125, 2021

2 de Lacy FB, "Transanal total mesorectal excision:pathological results of 186 patients with mid and low rectal cancer" 32 : 2442-2447, 2018

3 Penna M, "Transanal total mesorectal excision: international registry results of the first 720 cases" 266 : 111-117, 2017

4 Sparreboom CL, "Transanal total mesorectal excision: how are we doing so far?" 21 : 767-774, 2019

5 Persiani R, "Transanal total mesorectal excision vs laparoscopic total mesorectal excision in the treatment of low and middle rectal cancer: a propensity score matching analysis" 61 : 809-816, 2018

6 Chen CC, "Transanal total mesorectal excision versus laparoscopic surgery for rectal cancer receiving neoadjuvant chemoradiation: a matched case-control study" 23 : 1169-1176, 2016

7 Fernández-Hevia M, "Transanal total mesorectal excision in rectal cancer: short-term outcomes in comparison with laparoscopic surgery" 261 : 221-227, 2015

8 Chang TC, "Transanal total mesorectal excision in lower rectal cancer: comparison of short-term outcomes with conventional laparoscopic total mesorectal excision" 28 : 365-369, 2018

9 Mizrahi I, "Transanal total mesorectal excision for rectal cancer:a review" 2 : 144-, 2017

10 Wasmuth HH, "Transanal total mesorectal excision for rectal cancer has been suspended in Norway" 107 : 121-130, 2020

11 Roodbeen SX, "Transanal total mesorectal excision (TaTME) versus laparoscopic TME for MRI-defined low rectal cancer: a propensity score-matched analysis of oncological outcomes" 33 : 2459-2467, 2019

12 Rouanet P, "Transanal endoscopic proctectomy: an innovative procedure for difficult resection of rectal tumors in men with narrow pelvis" 56 : 408-415, 2013

13 Detering R, "Three-year nationwide experience with transanal total mesorectal excision for rectal cancer in the Netherlands: a propensity score-matched comparison with conventional laparoscopic total mesorectal excision" 228 : 235-244, 2019

14 Perdawood SK, "The pattern of defects in mesorectal specimens: is there a difference between transanal and laparoscopic approaches?" 108 : 49-54, 2019

15 Heald RJ, "The mesorectum in rectal cancer surgery-the clue to pelvic recurrence?" 69 : 613-616, 1982

16 Roberto Persiani, "The learning curve of TaTME for mid-low rectal cancer: a comprehensive analysis from a five-year institutional experience" Springer Science and Business Media LLC 35 (35): 6190-6200, 2021

17 Liberati A, "The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions:explanation and elaboration" 339 : b2700-, 2009

18 Rasulov AO, "Short-term outcomes after transanal and laparoscopic total mesorectal excision for rectal cancer" 20 : 227-234, 2016

19 Guillou PJ, "Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial" 365 : 1718-1726, 2005

20 Lelong B, "Short- and mid term outcomes after endoscopic transanal or laparoscopic transabdominal total mesorectal excision for low rectal cancer:a single institutional case-control study" 224 : 917-925, 2017

21 Heald RJ, "Rectal cancer:the Basingstoke experience of total mesorectal excision, 1978-1997" 133 : 894-899, 1998

22 Lujan J, "Randomized clinical trial comparing laparoscopic and open surgery in patients with rectal cancer" 96 : 982-989, 2009

23 Bjoern MX, "Quality of life after surgery for rectal cancer: a comparison of functional outcomes after transanal and laparoscopic approaches" 23 : 1623-1630, 2019

24 Veltcamp Helbach M, "Quality of life after rectal cancer surgery: differences between laparoscopic and transanal total mesorectal excision" 33 : 79-87, 2019

25 Efthimiou O, "Practical guide to the meta analysis of rare events" 21 : 72-76, 2018

26 Paun BC, "Postoperative complications following surgery for rectal cancer" 251 : 807-818, 2010

27 Thorpe H, "Patient factors influencing conversion from laparoscopically assisted to open surgery for colorectal cancer" 95 : 199-205, 2008

28 Penninckx F, "Outcome following laparoscopic and open total mesorectal excision for rectal cancer" 100 : 1368-1375, 2013

29 Larsen SG, "Norwegian moratorium on transanal total mesorectal excision" 106 : 1120-1121, 2019

30 Sylla P, "NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance" 24 : 1205-1210, 2010

31 Higgins JP, "Measuring inconsistency in meta-analyses" 327 : 557-560, 2003

32 Veldkamp R, "Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of arandomised trial" 6 : 477-484, 2005

33 Veldkamp R, "Laparoscopic resection of colon cancer:consensus of the European Association of Endoscopic Surgery (EAES)" 18 : 1163-1185, 2004

34 Pandya S, "Laparoscopic colectomy: indications for conversion to laparotomy" 134 : 471-475, 1999

35 Mege D, "Is trans-anal total mesorectal excision really safe and better than laparoscopic total mesorectal excision with a perineal approach first in patients with low rectal cancer?:a learning curve with case-matched study in 68 patients" 20 : O143-O151, 2018

36 Gachabayov M, "Is taTME delivering?" 71 : 13-15, 2019

37 Pikarsky AJ, "Is obesity a high-risk factor for laparoscopic colorectal surgery?" 16 : 855-858, 2002

38 Alamili M, "Inflammatory response after transanal total mesorectal excision" 66 : A5555-, 2019

39 Bray F, "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36cancers in 185 countries" 68 : 394-424, 2018

40 Rubinkiewicz M, "Functional outcomes after resections for low rectal tumors: comparison of transanal with laparoscopic total mesorectal excision" 19 : 79-, 2019

41 Caycedo-Marulanda A, "Experience beyond the learning curve of transanal total mesorectal excision (taTME) and its effect on the incidence of anastomotic leak" 24 : 309-316, 2020

42 Sean McGrath, "Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis" SAGE Publications 29 (29): 2520-2537, 2020

43 Hozo SP, "Estimating the mean and variance from the median, range, and the size of a sample" 5 : 13-, 2005

44 Quirke P, "Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial" 373 : 821-828, 2009

45 Stang A, "Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses" 25 : 603-605, 2010

46 Chen YT, "Comparison of the short-term outcomes in lower rectal cancer using three different surgical techniques: transanal total mesorect alexcision (T ME), laparoscopic TME, and open TME" 42 : 674-680, 2019

47 Lin HH, "Circumferential margin plays an independent impact on the outcome of rectal cancer patients receiving curative total mesorectal excision" 206 : 771-777, 2013

48 Nagtegaal ID, "Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit" 26 : 350-357, 2002

49 2017 European Society of Coloproctology(ESCP)collaborating group, "An international multicentre prospective audit of elective rectal cancer surgery;operative approach versus outcome, including transanal total mesorectal excision (TaTME)" 20 (20): 33-46, 2018

50 Abbott SC, "An assessment of an Australasian pathway for the introduction of transanal total mesorectal excision (taTME)" 20 : O1-O6, 2018

51 Krarup PM, "A nationwide study on anastomotic leakage after colonic cancer surgery" 14 : e661-e667, 2012

52 Di Candido F, "A comparative cost analysis of transanal and laparoscopic total mesorectal excision for rectal cancer" 73 : 85-91, 2021